GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » Gross Margin %

Black Bird Biotech (Black Bird Biotech) Gross Margin % : 25.00% (As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Black Bird Biotech's Gross Profit for the three months ended in Sep. 2023 was $0.00 Mil. Black Bird Biotech's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Black Bird Biotech's Gross Margin % for the quarter that ended in Sep. 2023 was 25.00%.


The historical rank and industry rank for Black Bird Biotech's Gross Margin % or its related term are showing as below:

BBBT' s Gross Margin % Range Over the Past 10 Years
Min: 19.23   Med: 39.76   Max: 50
Current: 36.11


During the past 13 years, the highest Gross Margin % of Black Bird Biotech was 50.00%. The lowest was 19.23%. And the median was 39.76%.

BBBT's Gross Margin % is ranked worse than
69.49% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.8 vs BBBT: 36.11

Black Bird Biotech had a gross margin of 25.00% for the quarter that ended in Sep. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Black Bird Biotech was 0.00% per year.


Black Bird Biotech Gross Margin % Historical Data

The historical data trend for Black Bird Biotech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Black Bird Biotech Gross Margin % Chart

Black Bird Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 50.00 19.23 39.76

Black Bird Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 16.67 42.86 53.85 25.00

Competitive Comparison of Black Bird Biotech's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Black Bird Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Black Bird Biotech's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Black Bird Biotech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Black Bird Biotech's Gross Margin % falls into.



Black Bird Biotech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Black Bird Biotech's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0 / 0.083
=(Revenue - Cost of Goods Sold) / Revenue
=(0.083 - 0.05) / 0.083
=39.76 %

Black Bird Biotech's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=0 / 0.004
=(Revenue - Cost of Goods Sold) / Revenue
=(0.004 - 0.003) / 0.004
=25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Black Bird Biotech  (OTCPK:BBBT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Black Bird Biotech had a gross margin of 25.00% for the quarter that ended in Sep. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Black Bird Biotech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Black Bird Biotech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Black Bird Biotech (Black Bird Biotech) Business Description

Traded in Other Exchanges
N/A
Address
11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.
Executives
Jeffrey A Collins director, 10 percent owner, officer: President 302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea director, 10 percent owner, officer: President, CEO, CFO, CAO 40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland director, 10 percent owner, officer: President, CEO, CFO & CAO C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2

Black Bird Biotech (Black Bird Biotech) Headlines

From GuruFocus